Establishment and characterization of a cisplatin-resistant human neuroblastoma cell line

Anticancer Research

Volumn 19, Issue 5 B, 1999, Pages 4049-4057

  Yasuno, Tetsuya ^b   Matsumura, Takafumi ^a   Shikata, Takuma ^b   Inazawa, Johji ^b   Sakabe, Tomoya ^b   Tsuchida, Shigeki ^b   Takahata, Takenori ^b   Miyairi, Shinichi ^b   Naganuma, Akira ^b   Sawada, Tadashi ^b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b NONE

Author keywords

Cisplatin; Drug resistance; Gultathione S transferase; Metallothionein; Neuroblastoma

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; METALLOTHIONEIN; PIRARUBICIN; TRANSPLATIN; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CHROMOSOME 1; CHROMOSOME 2; CONTROLLED STUDY; CROSS RESISTANCE; DRUG RESISTANCE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL;

EID: 0032786480     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Iwafuchi M, Utumi J, Tsuchida Y, Kaneko M, Matsuyama S, Ohnuma N, Taguchi N, Mugishima H, Yokoyama J, Sasaki S, Yoshioka A, Nagahara N, Fukuzawa M and Suita S: Evaluation of patients with advanced neuroblastoma more than 5 years after initiation of an intensive Japanese protocol: a report from the Study Group of Japan for Treatment of Advanced Neuroblastoma. Med Pediatr Oncol 27: 515-520, 1996.
2. Brodeur GM and Castleberry RP: Neuroblastoma. In: Principles and Practice of Pediatric Oncology, ed 3 (Pizzo AP and Poplack DG, eds). Philadelphia, Lippincott-Raven Publishers, 1997, pp 761-796.
3. Timmer-Bosscha H, Mulder NH and de Vries EGE: Modulation of cis-diamminedichloroplatinum(II) resistance: a review. Br J Cancer 66: 227-238, 1992.
4. Gately DP and Howell SB: Cellular accumulation of the anticancer agent cisplatin: A review. Br J Cancer 67: 1171-1176, 1993.
5. Ireland CM, Pittman SM, Jones SL and Harnett PR: Establishment of an in vitro model for cisplatin resistance in human neuroblastoma cell lines. Anticancer Res 14: 2397-2404, 1994.
6. Campling BG, Young LC, Baer KA, Lam Y-M., Deeley RG, Cole SPC and Gerlach JH: Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer. Clin Cancer Res 3: 115-122, 1997.
7. Bordow SB, Haber M, Madafiglio J, Cheung B, Marshall GM and Norris MD: Expression of the multidrug resistance associated protein (MRP) gene correlated with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma. Cancer Res 54: 5036-5040, 1994.
8. Norris MD, Bordow SB, Marshall GM, Haber PS, Cohn SL and Haber M: Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N Engl J Med 334: 231-238, 1996.
9. Sugimoto T, Sawada T, Matsumura T, Kemshead JT, Ishii T, Horii Y, Morioka H, Morita M and Reynolds CP: Identical expression of cell surface membrane antigens on two parent and eighteen cloned cell lines derived from two different neuroblastoma metastases of the same patient. Cancer Res 46: 4765-4769, 1986.
10. Ishiyama M, Shiga M, Sasamoto K, Mizuguchi M and He P-G: A new sulfonated tetrazolium salt that produces a high water-soluble formazan dye. Chem Pharm Bull 41: 1118-1122, 1993.
11. Matsumura T, Sugimoto T and Sawada T: Phenotypes of neuroblastoma cells as distinguished by monoclonal antibodies. In: Molecular biology & genetics of childhood cancers (Sluyser M and Voute PA, eds). Chichester, Ellis Horwood Limited, 1988, pp 38-55.
12. Sugimoto T, Ueyama H, Hosoi H, Inazawa J, Kato T, Kemshead JT, Reynolds CP, Gown AM, Mine H and Sawada T: Alpha-smooth-muscle actin and desmin expressions in human neuroblastoma cell lines. Int J Cancer 48: 277-283, 1991.
13. Pera MF Jr. and Harder HC: Analysis for platinum in biological material by flameless atomic absorption spectrometry. Clin Chem 23: 1245-1249, 1977.
14. Habig WH, Pabst MJ and Jakoby WB: Glutathion S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130-7139, 1974.
15. Takeoka N, Tsuchida S, Soma Y and Sato K: Purification and characterization of glutathione S-transferases in human kidney. Clin Chem Acta 166: 207-218, 1987.
16. Soma Y, Satoh K and Sato K: Purification and subunit-structural and immunological characterization of five glutathione S-transferases in human liver, and the acidic form as a hepatic tumor marker. Biochim Biophys Acta 869: 247-258, 1986.
17. Towbin H, Staehelin T and Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979.
18. Toyo'oka T and Imai K: High-performance liquid chromatography and fluorometric detection of biologically important thiols, derivatized with ammonium 7-fluorobenzo-2-1,3-diazole-4-sulphonte (SBD-F). J Chromatogr 282: 495-500, 1983.
19. Tanaka-Kagawa T, Naganuma A and Imura N: Tubular secretion and reabsorption of mercury compounds in mouse kidney. J Pharmacol Exp Therap 264: 776-782, 1993.
20. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
21. Miyairi S, Shibata S and Naganuma A: Determination of metallothionein by high-performance liquid chromatography with fluorescence detection using an isocratic solvent system. Anal Biochem 258: 168-175, 1998.
22. Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW and Pinkel D: Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10: 231-243 1994.
23. Horii Y, Sugimoto T, Sawada T, Imanishi J, Tuboi K and Hatanaka M: Differential expression of N-myc and c-src protooncogenes during neuronal and schwannian differentiation of human neuroblastoma cells. Int J Cancer 43: 305-309, 1989.
24. Dimitroulakos J and Yeger H: HMG-CoA reductase mediates the biological effects of retinoic acid on human neuroblastoma cells: Lovastatin specifically targets P-glycoprotein-expressing cells. Nature Med 2: 326-333, 1996.
25. Hong W-S, Saijo N, Sasaki Y, Minato K, Nakano H, Nakagawa K, Fujiwara Y, Nomura K and Twentyman PR: Establishment and characterization of cisplatin-resistant sublines of human lung cancer cell lines. Int J Cancer 41: 462-467, 1988.
26. Osmak M and Eljuga D: The characterization of two human cervical carcinoma HeLa sublines resistant to cisplatin. Res Exp Med 193: 389-396, 1993.
27. Belvedere G, Imperatori L, Damia G, Tagliabue G, Meijer C, de Vries EGE and D'Incalci M: In vitro and in vivo characterization of low-resistant mouse reticulosarcoma (M5076) sublines obtained after pulse and continuous exposure to cisplatin. Eur J Cancer 32A: 2011-2018, 1996.
28. Katabami M, Fujita H, Honke K, Makita A, Akita H, Miyamoto H, Kawakami Y and Kuzumaki N: Marked reduction of type I keratin (K14) in cisplatin-resistant human lung squamous-carcinoma cell lines. Biochem Phamacol 45: 1703-1710, 1993.
29. Parrrekh HK and Simpkins H: The differential expression of cytokeratin 18 in cisplatin-sensitive and -resistant human ovarian adenocarcinoma cells and its association with drug sensitivity. Cancer Res 55: 5203-5206, 1995.
30. Hanada M, Krajiwski S, Tanaka S, Cazals-Hatem D, Spengler BA, Ross RA, BiedlEr JL and Reed JC: Regulation of Bcl-2 oncoproteine levels with differentiation of human neuroblastoma cells. Cancer Res 53: 4978-4986, 1993.
31. Dole M, Nuñez G, Merchant KA, Maybaum J, Rode CK, Bloch CA and Castle VP: Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res 54: 3253-3259, 1994.
32. Lasorella A, Iavarone A and Israel MA: Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance. Cancer Res 55: 4711-4716, 1995.
33. Christen RD, Hom DK, Porter DC, Andrwes PA, MacLeod CL, Hafstrom L and Howell SB: Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatin. J Clin Invest 86: 1632-1640, 1990.
34. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV and Deeley RG: Overexpression of a transport gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654, 1992.
35. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SPC and Deeley RG: Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 54: 357-361, 1994.
36. Ishikawa T, Wright CD and Ishizuka H: GS-X pump is functionally overexpressed in cis-diamminedichloroplatinum(II)-resistant human leukemia HL-60 cells and down-regulated by cell differentiation. J Biol Chem 269: 29085-29093, 1994.
37. Ishikawa T, Bao J-J, Yamane Y, Akimaru K, Frindrich K, Wright CD and Kuo MT: Coordinated induction of MRP/GS-X pump and g-glutamylcysteine synthetase by heavy metals in human leukemia cells. J Biol Chem 271: 14981-14988, 1996.
38. Taniguchi K, Wada M, Kohno K, Nakamura T, Kawabe T and Kawakami M: A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res 56: 4124-4129, 1996.
39. Kasahara K, Fujiwara Y, Nishio K, Ohmori T, Sugimoto Y, Komiya K, Matsuda T and Saijo N: Metallothionein content correlates with the sensitivity of human small lung cancer cell lines to cisplatin. Cancer Res 51: 3237-3242, 1991.
40. Koropatnick J and Pearson J: Altered cisplatin and cadmium resistance and cell survival in Chinese hamster ovary cells expressing mouse metallothionein. Mol Pharmacol 44: 44-50, 1993.
41. Kelley SL, Basu A, Teicher BA, Hacker MP, Hamer DH and Lazo JS: Overexpression of metallothionein confers resistance to anticancer drugs. Science 241: 1813-1815, 1988.
42. Kondo Y, Woo ES, Michalska AE, Choo KH and Lazo JS: Metallothionein null cells have increased sensitivity to anticancer drugs. Cancer Res 55: 2021-2023, 1995.
43. Koropatnick J, Kloth DM, Kadhim S, Chin JL and Cherian MG: Metallothionein expression and resistance to cisplatin in a human germ cell tumor cell line. J Pharmacol Exp Ther 275: 1681-1687, 1945.
44. Hishikawa Y, Abe S, Kinugasa S, Yoshimura H, Monden N, Igarashi M, Tachibana M and Nagasue N: Overexpression of metallothionein correlates with chemoresistance to cisplatin and prognosis in esophageal cancer. Oncology 54: 342-347, 1997.
45. Nakagawa K, Saijo N, Tsuchida S, Sakai M, Tsunokawa Y, Yokota J, Muramatsu M, Sato K, Terada M and Tew KD: Glutathione-S-transferase p as a determination of drug resistance in transfectant cell lines. J Biol Chem 265: 4296-4301, 1990.
46. Miyara H, Hida T, Nishida K, Takahashi T, Sugiura T, Ariyoshi Y, Morishita M, Takahashi T and Ueda R: Modification of chemoradiosensitivity of a human lung cancer cell line by introduction of the glutathione S-transferase p gene. Jpn J Clin Oncol 26: 1-5, 1996.
47. Miyazaki M, Kohno K, Saburi Y, Matsuo K, Ono M, Kuwano M, Tsuchida S, Sato K, Sakai M and Muramatsu M: Drug resistance to cis-diamminedichloroplatinum (II) in Chinese hamster ovary cell lines transfected with glutathione-S-transferase p gene. Biochem Biophys Res Commun 166: 1358-1364, 1990.
48. Okuyama T, Maehara Y, Endo K, Baba H, Adachi Y, Kuwano M and Sugimachi K: Expression of glutathione S-transferase-pi and sensitivity of human gastric cancer cells to cisplatin. Cancer 74: 1230-1236, 1994.
49. Murata T, Hatayama I, Kakizaki I, Satoh K, Sato K and Tsuchida S: Lentinan enhances sensitivity of mouse colon 26 tumor to cis-diamminedichloroplatinum (II) and decreases glutathione transferase expression. Jpn J Cancer Res 87: 1171-1178, 1996.
50. Kuroda H, Sugimoto T, Ueda K, Tuchida S, Horii Y, Inazawa J, Sato K and Sawada T: Different drug sensitivity in two neuroblastoma cell lines established from the same patient before and after chemotherapy. Int J Cancer 47: 732-737, 1191.
51. Norris MD, Bordow SB, Haber PS, Marshall GM, Kavallaris M, Madafiglio J, Cohn SL, Salwen H, Schmidt ML, Hipfner DR, Cole SP, Deeley RG and Haber M: Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma. Eur J Cancer 33: 1911-1916, 1997.